Showing results (21-30 of 108) with videos related to
Sort By:
Pageof 11
Breast Cancer (Tokyo, Japan)|January 20, 2005
Two cases of breast cancer with cartilaginous and osseous metaplasiaJun Ninomiya, Tetsunari Oyama, Jun Horiguchi, et al.Journal of Contemporary Brachytherapy|December 6, 2017
Independent assessment of source position for gynecological applicator in high-dose-rate brachytherapyHiroyuki Okamoto, Satoshi Nakamura, Shie Nishioka, et al.Igaku Butsuri : Nihon Igaku Butsuri Gakkai Kikanshi = Japanese Journal of Medical Physics : an Official Journal of Japan Society of Medical Physics|March 5, 2019
[On-line Adaptive Radiotherapy Using MRI-Guided Technique]Hiroyuki Okamoto, Tatsuya Sakasai, Shie Nishioka, et al.Journal of Applied Clinical Medical Physics|December 19, 2025
Patient-specific quality assurance for extremely small field sizes using 3D in vivo dosimetry in fractionated stereotactic radiosurgery for brain metastasesKenichi Jumonji, Jun Takatsu, Naoya Hara, et al.Breast Cancer (Tokyo, Japan)|November 25, 2003
Long-term suppression of lymphangitic lung metastasis from breast cancer using biweekly docetaxel: a case reportJun Ninomiya, Jun Horiguchi, Yukio Koibuchi, et al.Brachytherapy|July 28, 2024
Development and promotion of a 3D-printed phantom model for ultrasound-guided caudal block followed by intracavitary/interstitial brachytherapy for gynecological cancerTerufumi Kawamoto, Masaki Oshima, Naoya Murakami, et al.Medical Oncology (Northwood, London, England)|September 15, 2019
Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancerMayuko Ito, Yoshiya Horimoto, Emi Tokuda, et al.Oncology Reports|October 8, 2005
Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancerJun Horiguchi, Yukio Koibuchi, Kotaro Iijima, et al.Journal of Translational Medicine|October 22, 2018
Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot studyYoshiya Horimoto, Emi Tokuda, Fumi Murakami, et al.Breast Cancer (Tokyo, Japan)|November 8, 2014
Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospitalAkiko Ogiya, Kiyomi Kimura, Eri Nakashima, et al.Pageof 11